ImmuPharma Market Cap

ImmuPharma has a market cap or net worth of 35.19 million as of March 6, 2026. Its market cap has increased by 67.67% in one year.

Market Cap

35.19M

Enterprise Value

34.79M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

7.00

Market Cap Chart

Since February 22, 2006, ImmuPharma's market cap has decreased from 36.11M to 35.19M, a decrease of -2.55%. That is a compound annual growth rate of -0.13%.

Market Cap History

Date	Market Cap	% Change
Mar 5, 2026	35.89M	15.16%
Dec 31, 2025	31.17M	521.13%
Dec 31, 2024	5.02M	-27.71%
Dec 29, 2023	6.94M	13.16%
Dec 30, 2022	6.13M	-62.85%
Dec 31, 2021	16.51M	-50.56%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Poolbeg Pharma	29.61M
Arecor Therapeutics	27.18M
SkinBioTherapeutics	24.78M
Aptamer Group	22.92M
Ondine Biomedical	53.25M
Sareum Holdings	21.40M
hVIVO	57.15M
Hemogenyx Pharmaceuticals	60.33M

Market Cap Rankings